Medical devices, healthcare technology and the business of care
PMA approval · P140019

I-FACTOR PEPTIDE ENHANCED BONE GRAFT

Cerapedics, LLC · Decision date Nov 3, 2015

FDA DECISIONP140019

What did the FDA approve?

FDA records P140019 as an original PMA application. The recorded decision is approval, dated Nov 3, 2015.

FDA approval order statement

APPROVAL FOR THE I-FACTOR PEPTIDE ENHANCED BONE GRAFT. THIS COMBINATION PRODUCT IS INDICATED FOR USE IN SKELETALLY MATURE PATIENTS FOR RECONSTRUCTION OF A DEGENERATED CERVICAL DISC AT ONE LEVEL FROM C3-C4 TO C6-C7 FOLLOWING SINGLE-LEVEL DISCECTOMY FOR INTRACTABLE RADICULOPATHY (ARM PAIN AND/OR A NEUROLOGICAL DEFICIT), WITH OR WITHOUT NECK PAIN, OR MYELOPATHY DUE TO A SINGLE-LEVEL ABNORMALITY LOCALIZED TO THE DISC SPACE, AND CORRESPONDING TO AT LEAST ONE OF THE FOLLOWING CONDITIONS CONFIRMED BY RADIOGRAPHIC IMAGING (CT, MRI, X-RAYS): HERNIATED NUCLEUS PULPOSUS, SPONDYLOSIS (DEFINED BY THE PRESENCE OF OSTEOPHYTES), AND/OR VISIBLE LOSS OF DISC HEIGHT AS COMPARED TO ADJACENT LEVELS, AFTER FAILURE OF AT LEAST 6 WEEKS OF CONSERVATIVE TREATMENT. I-FACTOR PEPTIDE ENHANCED BONE GRAFT P-15 PUTTY MUST BE USED INSIDE AN ALLOGRAFT BONE RING AND WITH SUPPLEMENTAL ANTERIOR PLATE FIXATION.
Regulatory pathway
Original PMA
Clinical specialty
Orthopedic
Decision date
Nov 3, 2015

FDA source record

Regulatory record facts

Identifier
P140019
Regulatory pathway
Premarket approval application
Product code
NOX
Decision code
APPR
Decision date
Nov 3, 2015
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Filler, bone void, synthetic peptide.

Product code
NOX
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P140019 received

    Application receipt date recorded by FDA.

  2. P140019 · FDA decision

    APPR

  3. P140019/S014 · Related supplement

    i-F ACTOR Peptide Enhanced Graft Substitute

Timeline entries are records held by MedtechLedger for P140019. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P140019

Product / regulatory recordCompanyPathwayDecision dateSource
Cerapedics, LLCPMA supplementSep 16, 2026FDA

Explore the linked device profile

Other records with product code NOX

Product / regulatory recordCompanyPathwayDecision dateSource
Cerapedics, Inc.PMA supplementSep 16, 2026FDA
Cerapedics, Inc.PMA approvalJun 18, 2025FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Cerapedics, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
11025 Dover St., Suite 1600, Westminster, CO, 80021

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records